Coya Therapeutics (COYA) Enterprise Value (2022 - 2025)
Historic Enterprise Value for Coya Therapeutics (COYA) over the last 4 years, with Q3 2025 value amounting to -$28.1 million.
- Coya Therapeutics' Enterprise Value rose 955.03% to -$28.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$28.1 million, marking a year-over-year increase of 955.03%. This contributed to the annual value of -$38.3 million for FY2024, which is 1751.01% down from last year.
- According to the latest figures from Q3 2025, Coya Therapeutics' Enterprise Value is -$28.1 million, which was up 955.03% from -$29.8 million recorded in Q2 2025.
- Coya Therapeutics' Enterprise Value's 5-year high stood at -$5.9 million during Q4 2022, with a 5-year trough of -$38.3 million in Q4 2024.
- In the last 4 years, Coya Therapeutics' Enterprise Value had a median value of -$30.4 million in 2024 and averaged -$26.2 million.
- Its Enterprise Value has fluctuated over the past 5 years, first tumbled by 44985.52% in 2023, then soared by 1857.92% in 2025.
- Quarter analysis of 4 years shows Coya Therapeutics' Enterprise Value stood at -$5.9 million in 2022, then tumbled by 449.86% to -$32.6 million in 2023, then dropped by 17.51% to -$38.3 million in 2024, then increased by 26.63% to -$28.1 million in 2025.
- Its last three reported values are -$28.1 million in Q3 2025, -$29.8 million for Q2 2025, and -$35.5 million during Q1 2025.